RIVA, MARCO ANDREA
RIVA, MARCO ANDREA
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Sex-specific metabolic and inflammatory alterations in adult animals vulnerable to prenatal stress exposure
2025 I. D'Aprile, G. Petrillo, V. Zonca, M. Mazzelli, F. De Cillis, M.G. Di Benedetto, M.A. Riva, A. Cattaneo
Inflammatory status along the brain-liver axis in animals vulnerable to prenatal stress: sex-related implications for stress-induced comorbidities
2025 I. D'Aprile, G. Petrillo, V. Begni, K.C. Creutzberg, R. Orso, R. Grassi-Oliveira, M.A. Riva, A. Cattaneo
Exposure to early-life stress uncovers shared biological signatures underlying vulnerability in the habenula and insular cortex of male and female adult rats
2025 V. Zonca, M. Marizzoni, S. Saleri, M. Mazzelli, G. Petrillo, M.G. Di Benedetto, F. De Cillis, M.A. Riva, A. Cattaneo
Restorative properties of chronic lurasidone treatment on emotional dysfunction in rats exposed to chronic unavoidable stress: A role for medial prefrontal cortex - nucleus accumbens network
2025 E. Corridori, S. Salviati, V. Begni, A. Marchesin, C. Gambarana, M.A. Riva, S. Scheggi
Understanding, predicting, and treating depression in pregnancy to improve mothers' and offspring's mental health outcomes: The HappyMums study
2025 A. Biaggi, V. Zonca, C. Anacker, V. Begni, F. Benedetti, A. Bramante, A. Braniecka, V. Brenna, M. Bulgheroni, C. Buss, L. Cavaliere, C.A.M. Cecil, A.C. Couch, D. De Barra, H. El Marroun, S. Entringer, R. Grassi-Oliveira, M. Jackowska, A. Korosi, P.J.C. Kwant, J. Lahti, K. Lekadir, I. Mansuy, F. Manuella, M. Marizzoni, U. Meyer, C. Monk, S.N. Radoš, C.M. Pariante, B.J.A. Pollux, K. Priestley, K. Räikkönen, J. Richetto, M.A. Riva, L.M. Rothmann, V. Simonetti, B. Vai, A.C. Vernon, M. Žutić, A. Cattaneo
IUPHAR review - Novel therapeutic targets for schizophrenia treatment: A translational perspective
2025 V. Begni, A. Marchesin, M.A. Riva
Emotional dysregulation following prenatal stress is associated with altered prefrontal cortex responsiveness to an acute challenge in adolescence
2025 R. Orso, K.C. Creutzberg, V. Begni, G. Petrillo, A. Cattaneo, M.A. Riva
Chronic treatment with the antipsychotic lurasidone modulates the neuroinflammatory changes associated with the vulnerability to chronic mild stress exposure in female rats
2025 V. Begni, D.M. Silipo, C. Bottanelli, M. Papp, A. Cattaneo, M.A. Riva
Inflammation and immune system pathways as biological signatures of adolescent depression—the IDEA-RiSCo study
2024 V. Zonca, M. Marizzoni, S. Saleri, Z. Zajkowska, P.H. Manfro, L. Souza, A. Viduani, L. Sforzini, J.R. Swartz, H.L. Fisher, B.A. Kohrt, C. Kieling, M.A. Riva, A. Cattaneo, V. Mondelli
Dissecting the Long-Term Effect of Stress Early in Life on FKBP5: The Role of miR-20b-5p and miR-29c-3p
2024 N. Cattane, M.G. Di Benedetto, I. D'Aprile, M.A. Riva, A. Cattaneo
Transcriptomic analyses of rats exposed to chronic mild stress: Modulation by chronic treatment with the antipsychotic drug lurasidone
2024 V. Begni, M. Marizzoni, K.C. Creutzberg, D.M. Silipo, M. Papp, A. Cattaneo, M.A. Riva
Transcriptomic profiles in major depressive disorder: the role of immunometabolic and cell-cycle-related pathways in depression with different levels of inflammation
2024 L. Sforzini, M. Marizzoni, C. Bottanelli, V. Kunšteková, V. Zonca, S. Saleri, M. Kose, G. Lombardo, N. Mariani, M.A. Nettis, N. Nikkheslat, C. Worrell, Z. Zajkowska, L. Pointon, P.J. Cowen, J. Cavanagh, N.A. Harrison, M.A. Riva, V. Mondelli, E.T. Bullmore, N. Null, A. Cattaneo, C.M. Pariante
The complex scenario behind the term antipsychotic drug
2024 M.A. Riva, A. Cattaneo
Molecular mechanisms underlying stress vulnerability and resilience in the chronic mild stress model: New insights from mRNA and miRNAs data combining
2024 N. Cattane, M. Mazzelli, V. Begni, E. Mombelli, M. Papp, C. Maj, M.A. Riva, A. Cattaneo
Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations
2024 A. Vita, S. Barlati, R. Cavallaro, A. Mucci, M.A. Riva, P. Rocca, A. Rossi, S. Galderisi
Early life adversities, psychopathologies and novel pharmacological strategies
2024 A. Cattaneo, V. Begni, V. Zonca, M.A. Riva
Reduced sociability in a prenatal immune activation model: Modulation by a chronic blonanserin treatment through the amygdala-hippocampal axis
2023 K. Deriha, E. Hashimoto, W. Ukai, F. Marchisella, E. Nishimura, H. Hashiguchi, M. Tayama, T. Ishii, M.A. Riva, C. Kawanishi
The Natural Protoalkaloid Methyl-2-Amino-3-Methoxybenzoate (MAM) Alleviates Positive as well as Cognitive Symptoms in Rat and Mouse Schizophrenia Models
2023 Y. Bright, D.A. Maas, M.M.M. Verheij, M.S. Paladini, H.I.V. Amatdjais-Groenen, R. Molteni, M.A. Riva, G.J.M. Martens, J.R. Homberg
A systematic review and multilevel meta-analysis of the prenatal and early life stress effects on rodent microglia, astrocyte, and oligodendrocyte density and morphology
2023 R. Orso, K.C. Creutzberg, F.S. Lumertz, E. Kestering-Ferreira, B.A. Stocchero, M.K. Perrone, V. Begni, R. Grassi-Oliveira, M.A. Riva, T.W. Viola
Early effects of lurasidone treatment in a chronic mild stress model in male rats
2023 K.C. Creutzberg, V. Begni, F. Marchisella, M. Papp, M.A. Riva